12:00 AM
Aug 22, 2011
 |  BC Week In Review  |  Company News  |  Deals

Inviragen, University of Texas Medical Branch deal

The university granted partner Inviragen exclusive, worldwide rights to a chikungunya virus (CHIKV) vaccine. The recombinant CHIKV vaccine constructed by making defined alterations in the regions of...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >